Danaher Corp (NY:DHR)

234.07 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

30 31 Next >

Danaher's Options Frenzy: What You Need to Know ↗

February 12, 2025

Via Benzinga

3 Healthcare Stocks Skating on Thin Ice

February 12, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But near-term speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and...

Via StockStory

Topics Stocks

Waters Corporation Earnings: What To Look For From WAT

February 11, 2025

Scientific instruments company Waters Corporation (NYSE:WAT) will be reporting earnings tomorrow before the bell. Here’s what to look for.

Via StockStory

Danaher Unusual Options Activity For February 07 ↗

February 07, 2025

Via Benzinga

Jim Cramer Likes This Utilities Stock: 'I Think You've Got A Good One' ↗

February 07, 2025

NextEra Energy posted in-line earnings for the fourth quarter and said it continues to expect adjusted EPS of $3.45-$3.70 for fiscal 2025.

Via Benzinga

Danaher's Options: A Look at What the Big Money is Thinking ↗

February 03, 2025

Via Benzinga

Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years ↗

January 30, 2025

Via Benzinga

Danaher Analysts Cut Their Forecasts After Downbeat Earnings ↗

January 30, 2025

Via Benzinga

Avantor Earnings: What To Look For From AVTR

February 06, 2025

Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market hours. Here’s what you need to know.

Via StockStory

Earnings To Watch: Mettler-Toledo (MTD) Reports Q4 Results Tomorrow

February 05, 2025

Precision measurement company Mettler-Toledo (NYSE:MTD) will be announcing earnings results tomorrow after market close. Here’s what to expect.

Via StockStory

This FedEx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗

February 03, 2025

Via Benzinga

Danaher’s (NYSE:DHR) Q4 Sales Beat Estimates

January 31, 2025

Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.1% year on year to $6.54 billion. Its non-GAAP profit of $2.14 per...

Via StockStory

Topics Earnings

Broad-Based Sector Growth Expected For 2025 ↗

January 29, 2025

Total earnings for the 112 S&P 500 companies that have reported results are up +10.8% from the same period last year on +5.5% higher revenues, with 80.4% beating EPS estimates and 68.8% beating revenue...

Via Talk Markets

Topics Stocks Stocks / Equities

Beyond The Numbers: 5 Analysts Discuss Danaher Stock ↗

January 29, 2025

Via Benzinga

Danaher Unusual Options Activity ↗

January 28, 2025

Via Benzinga

$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today ↗

January 15, 2025

Via Benzinga

In today's session, there are S&P500 stocks with remarkable trading volume. ↗

January 29, 2025

Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Wednesday. Stay informed about the market activity below.

Via Chartmill

Wednesday's session: top gainers and losers in the S&P500 index ↗

January 29, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday.

Via Chartmill

What's going on in today's session: S&P500 gap up and gap down stocks ↗

January 29, 2025

Curious about the S&P500 stocks that are gapping on Wednesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Wednesday's pre-market session: top gainers and losers in the S&P500 index ↗

January 29, 2025

Pre-market stock analysis of S&P500 stocks on 2025-01-29: top gainers and losers in today's session.

Via Chartmill

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today ↗

January 02, 2025

Via Benzinga

Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years ↗

December 24, 2024

Via Benzinga

Stocks Tick Down Ahead Of Fed Meeting, Nvidia Jitters Resume, Trump Media Rallies: What's Driving Markets Wednesday? ↗

January 29, 2025

Caution dominates Wednesday's midday trading session in New York as investors anxiously await the Federal Open Market Committee decision at 2 p.m. ET.

Via Benzinga

Topics Economy Government

Manhattan Associates, LendingClub And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

January 29, 2025

Via Benzinga

Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag ↗

January 29, 2025

Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in biotechnology and life sciences.

Via Benzinga

Topics Earnings

Earnings Scheduled For January 29, 2025 ↗

January 29, 2025

Via Benzinga

Jim Cramer Recommends Buying 'Fabulous' BlackRock, Calls Coterra Energy The 'Cheapest' Natural Gas Company ↗

January 28, 2025

Cramer comments on Danaher, Coterra, BlackRock and Digital Realty. As for Grail, "Just great science, but it is parabolic," he adds.

Via Benzinga

Topics Energy

3 Insanely Cheap Stocks to Buy ↗

January 25, 2025

The object is to buy low and sell high.

Via The Motley Fool

Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery ↗

January 24, 2025

Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely.

Via Benzinga

Aldevron Unveils Next-Generation Alchemy™ Cell-Free DNA Technology for Research Grade Applications

January 21, 2025

From Aldevron

Via Business Wire

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.